FR2600341B1 - Procede de purification d'un produit d'expression genetique obtenu par technique d'adn recombinant - Google Patents

Procede de purification d'un produit d'expression genetique obtenu par technique d'adn recombinant

Info

Publication number
FR2600341B1
FR2600341B1 FR878708470A FR8708470A FR2600341B1 FR 2600341 B1 FR2600341 B1 FR 2600341B1 FR 878708470 A FR878708470 A FR 878708470A FR 8708470 A FR8708470 A FR 8708470A FR 2600341 B1 FR2600341 B1 FR 2600341B1
Authority
FR
France
Prior art keywords
purification
gene expression
product obtained
recombinant dna
expression product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR878708470A
Other languages
English (en)
Other versions
FR2600341A1 (fr
Inventor
Hideo Goda
Toshiyuki Akiyama
Akihisa Takamizawa
Iwao Yoshida
Takeo Konobe
Keisuke Takaku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation for Microbial Diseases of Osaka University BIKEN
Original Assignee
Research Foundation for Microbial Diseases of Osaka University BIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation for Microbial Diseases of Osaka University BIKEN filed Critical Research Foundation for Microbial Diseases of Osaka University BIKEN
Publication of FR2600341A1 publication Critical patent/FR2600341A1/fr
Application granted granted Critical
Publication of FR2600341B1 publication Critical patent/FR2600341B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR878708470A 1986-06-18 1987-06-17 Procede de purification d'un produit d'expression genetique obtenu par technique d'adn recombinant Expired - Lifetime FR2600341B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61143413A JPH0789951B2 (ja) 1986-06-18 1986-06-18 遺伝子発現産物の精製法

Publications (2)

Publication Number Publication Date
FR2600341A1 FR2600341A1 (fr) 1987-12-24
FR2600341B1 true FR2600341B1 (fr) 1992-03-13

Family

ID=15338189

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878708470A Expired - Lifetime FR2600341B1 (fr) 1986-06-18 1987-06-17 Procede de purification d'un produit d'expression genetique obtenu par technique d'adn recombinant

Country Status (4)

Country Link
US (1) US4902783A (fr)
JP (1) JPH0789951B2 (fr)
CA (1) CA1276899C (fr)
FR (1) FR2600341B1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486473A (en) * 1986-05-06 1996-01-23 The Research Foundation For Microbial Diseases Of Osaka University A DNA coding for a Flavivirus antigen
JPH0768267B2 (ja) * 1986-06-05 1995-07-26 財団法人阪大微生物病研究会 フラビウイルス抗原
US5026828A (en) * 1987-02-27 1991-06-25 Merck & Co., Inc. Method of purifying recombinant pres-1/S-2/S/S hepatitis B antigen from yeast
EP0310178A1 (fr) * 1987-09-30 1989-04-05 Merck & Co. Inc. Purification de l'antigène preS2+S
US5011915A (en) * 1987-10-26 1991-04-30 Merck & Co., Inc. Process for purifying recombinant hepatitis antigens
US5081584A (en) * 1989-03-13 1992-01-14 United States Of America Computer-assisted design of anti-peptides based on the amino acid sequence of a target peptide
DE69013471T2 (de) * 1989-12-05 1995-03-30 Merck & Co Inc Methode zur Stabilisierung von rekombinanten Hepatitis-B-Virus-Oberflächenproteinen aus Hefe.
US5460964A (en) * 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
US5436151A (en) * 1992-04-03 1995-07-25 Regents Of The University Of Minnesota Method for culturing human hematopoietic stem cells in vitro
US5451660A (en) * 1993-12-13 1995-09-19 Genentech, Inc. Method for purifying polypeptides
SE9600796D0 (sv) * 1996-02-29 1996-02-29 Pharmacia Biotech Ab A method of preparing a liquid mixture
DE19737917B4 (de) * 1996-08-26 2008-11-06 InViTek Gesellschaft für Biotechnik & Biodesign mbH Verfahren zum Nachweis klinisch relevanter Veränderungen der DNS-Sequenz des Ki-ras-Onkogens, seine Verwendung und Testkit zur Früherkennung von Tumoren
US6495089B1 (en) 2000-07-18 2002-12-17 Graham Packaging Company, L.P. Blow-molded container and closure, and method and apparatus for making same
US9650411B2 (en) 2012-08-07 2017-05-16 Kyowa Hakko Kirin Co., Ltd. Method of purifying protein
KR101704462B1 (ko) * 2013-02-26 2017-02-09 이엠디 밀리포어 코포레이션 용액 조건을 조정하는 것에 의해 활성탄을 사용하여 단백질의 혼합물로부터 단백질의 선택적 제거

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US4503035B1 (en) * 1978-11-24 1996-03-19 Hoffmann La Roche Protein purification process and product
JPH0625069B2 (ja) * 1981-01-29 1994-04-06 ブリティッシュ・テクノロジー・グループ・リミテッド Ｂ型肝炎ワクチン製造方法
US4525459A (en) * 1982-01-27 1985-06-25 University Of Miami New purified glycoproteins and use in diagnosing infectious mononucleosis
GR76274B (fr) * 1981-08-04 1984-08-04 Univ California
DE3149360A1 (de) * 1981-12-12 1983-06-16 Biotest-Serum-Institut Gmbh, 6000 Frankfurt "verfahren zur reinigung und/oder phytohaemagglutinin-abtrennung von human-interleukin-2"
US4514506A (en) * 1982-02-23 1985-04-30 The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services Method for the identification and purification of human lung tumor-associated antigens (hLTAA) and clinical detection and determination of these antigens
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
AU590711B2 (en) * 1982-10-13 1989-11-16 Biowhittaker, Inc. Stable allergenic extracts and methods
SE8205892D0 (sv) * 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
JPS59101426A (ja) * 1982-11-29 1984-06-12 Green Cross Corp:The Ｂ型肝炎感染予防用ワクチンの製造方法
JPS59159792A (ja) * 1983-02-28 1984-09-10 Meiji Seika Kaisha Ltd カゼインホスホペプチドの製造法
JPS6098988A (ja) * 1983-11-01 1985-06-01 Chemo Sero Therapeut Res Inst Ｌｐｆ−ｈａの精製法
US4508709A (en) * 1983-12-05 1985-04-02 Armour Pharmaceutical Company Process for purifying factor VIII:C
US4552758A (en) * 1983-12-20 1985-11-12 St. Jude Children's Research Hospital Human use of avian-human reassortants as vaccines for influenza A virus
JPS60197629A (ja) * 1984-03-16 1985-10-07 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
SE8402861L (sv) * 1984-05-28 1985-11-29 Stefan Svenson Rening av biologiskt material
JPS60258127A (ja) * 1984-06-04 1985-12-20 Green Cross Corp:The Ｂ型肝炎ワクチンの製造方法
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate

Also Published As

Publication number Publication date
FR2600341A1 (fr) 1987-12-24
US4902783A (en) 1990-02-20
CA1276899C (fr) 1990-11-27
JPS63297A (ja) 1988-01-05
JPH0789951B2 (ja) 1995-10-04

Similar Documents

Publication Publication Date Title
FR2600341B1 (fr) Procede de purification d'un produit d'expression genetique obtenu par technique d'adn recombinant
FR2601383B2 (fr) Vecteurs perfectionnes d'expression de l'hirudine dans les levures, procede et produit obtenu
FR2555199B1 (fr) Procede de clivage d'adn bicatenaire en n'importe quel point donne
FR2603899B1 (fr) Procede perfectionne pour l'expression de recombinants
IT8267522A0 (it) Procedimento per la produzione di dna complementare rappresentante sequenze virali di rna mediante metodi del dna ricombinante prodotti relativi e loro usi
FR2619380B1 (fr) Procede de recuperation de l-amino-acides de liqueurs de fermentation les contenant
MA21922A1 (fr) Procede de purification d'acides aminomethylene-phosphoniques .
IT8819009A0 (it) Procedimento perfezionato per laproduzione di riso ibrido.
EP0354246A4 (fr) 5'-Phosphonates de 3'-azido-2',3'-didesoxynucleosides.
MA23832A1 (fr) Derives d'acide hydroxamique nouveaux, procede pour leur production et compositions les contenant
FR2581381B1 (fr) Procede de production de butene-1 de purete amelioree a partir du produit brut de dimersion de l'ethylene
FR2528070B1 (fr) Vecteur d'expression porteur d'un codage genetique pour une proteine liant les phosphates, procede pour sa preparation et procede de production d'un polypeptide en l'utilisant
FR2573757B1 (fr) Procede de separation de l-phenylalanine d'une solution la contenant
DE69011719D1 (de) Verfahren zur Synthese von Acylamino-organosilicium-Verbindungen.
DE69010956D1 (de) Verfahren zur Synthese von Acylaminogruppen enthaltenden Siliziumverbindungen.
FR2588265B3 (fr) Procede d'adoucissement d'une charge d'hydrocarbures contenant des produits soufres
FR2644474B1 (fr) Procede de purification d'enzymes
DE69006888D1 (de) Verfahren zur Synthese von Acylamino-Organosilicon-Verbindungen.
FR2589331B1 (fr) Procede de preparation d'un produit laitier fermente
FR2588879B1 (fr) Procede d'hydrotraitement des charges hydrocarbonees
FR2595058B1 (fr) Procede d'enrichissement d'un minerai sulfure
BE878077A (fr) Procede de purification d'amines tertiaires
DE3888260D1 (de) Verfahren zum Herstellen von Kohlenstoffmaterialien.
BE889035A (fr) Procede d'epuration de produits de reaction
FR2595714B1 (fr) Procede perfectionne de production d'interleukine-0

Legal Events

Date Code Title Description
ST Notification of lapse